Le Lézard
Classified in: Health
Subject: PER

NCPDP Announces Highlights from its 2024 Annual Conference, "Innovation Starts Here"


Highlights Include Keynotes on Future of Pharmacy and Technology Innovation, Newly Elected Board Members, Award Recipients and More

SCOTTSDALE, Ariz. , May 8, 2024 /PRNewswire-PRWeb/ -- NCPDP announced today highlights from its 2024 Annual Technology & Business Conference, Innovation Starts Here. "NCPDP's standards and guidance are inherently innovative, and the work we continue to do will expand interoperability to support the evolving role of pharmacists as an integral part of the patient care team" said Lee Ann Stember, President & CEO of NCPDP. "The goal is to relieve pharmacists of administrative burdens so they can operate at the top of their license and receive payment for their clinical services." The Annual Conference included riveting keynote speakers, topical educational sessions, big reveals on member and industry award recipients, and networking opportunities.

The conference opened with a powerhouse Keynote panel Pharmacists Today...5 Years from Now...10 Years from Now and Beyond with six high-profile experts featuring government officials, pharmacy visionaries, patient advocacy champions, and industry analysts on key topics including reimbursement, workforce challenges and opportunities, policy/regulation, and more.

Emmy-winning Keynote speaker, David Pogue, a best-selling author, journalist and the go-to expert on disruptive tech and science in a fast-changing world, gave a highly informative and entertaining address on the future of healthcare and artificial intelligence. Featured speaker and conference favorite, Doug Long, returned to deliver his informative IQVIAtm Market Trends Report, with co-presenter Scott Biggs. Rockstar-turned-motivator and closing Keynoter Mark Schulman, gave a high-energy and thrilling performance while teaching secrets to "Hacking the Rockstar Attitude".

Other Conference Highlights:

NCPDP's 2025 Annual Technology & Business Conference will be held May 5-7, 2025, at the Westin Kierland Resort & Spa in Scottsdale, Arizona.

About NCPDP
The National Council for Prescription Drug Programs (NCPDP) is a not-for-profit American National Standards Institute (ANSI) Accredited Standards Developer (ASD) consisting of more than 1,500 members representing entities including, but not limited to, claims processors, data management and analysis vendors, federal and state government agencies, insurers, intermediaries, pharmaceutical manufacturers, pharmacies, pharmacy benefit managers, professional services organizations, software and system vendors and other parties interested in electronic standardization within the pharmacy services sector of the healthcare industry. NCPDP provides a forum wherein our diverse membership can develop business solutions, including ANSI-accredited standards and guidance for promoting information exchanges related to medications, supplies and services within the healthcare system.

NCPDP has been named in federal legislation, including HIPAA, MMA, and HITECH. NCPDP members have created standards such as the Telecommunication Standard and Batch Standard, the SCRIPT Standard for ePrescribing, the Manufacturers Rebate Standard and more to improve communication within the pharmacy industry. Our data products include dataQ®, a robust database of information on more than 80,000 pharmacies, resQtm, an industry pharmacy credentialing resource, and HCIdea®, an innovative prescriber database that provides continually updated information on more than 2.5 million prescribers. NCPDP's RxReconn® is a legislative tracking product for real-time monitoring of pharmacy-related state and national legislative and regulatory activity. For more information about NCPDP Standards, Data Services, Products, Educational Programs and Work Group meetings, go online at http://www.ncpdp.org or call 480.477.1000.

Media Contact

Janet Cabibbo, NCPDP, 480-477-1000 x104, [email protected], www.NCPDP.org

Maggie Bruce, NCPDP, 480-477-1000 x144, [email protected], www.NCPDP.org

Twitter

SOURCE NCPDP


These press releases may also interest you

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...



News published on and distributed by: